Table of Content


Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 In-vitro colorectal cancer screening tests industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Test type trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 In-Vitro Colorectal Cancer Screening Tests Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 – 2027 (USD Million)
3.3 Industry impact factors
3.3.1 Growth drivers
3.3.1.1 Improvements in colorectal cancer screening through non-invasive methods
3.3.1.2 Advancements in the field of cancer diagnosis
3.3.1.3 Rising prevalence of colorectal cancer
3.3.1.4 Cost-efficient and high-speed DNA sequencing
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of uniform cancer screening guidelines in Asia Pacific
3.3.2.2 Inadequate reimbursement coverage
3.3.2.3 Shortage of trained staff in developing regions
3.4 Growth potential analysis
3.4.1 By test type
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2020
3.7.1 Company matrix analysis, 2020
3.8 PESTEL analysis
Chapter 4 In-Vitro Colorectal Cancer Screening Tests Market, By Test Type
4.1 Key segment trends
4.2 Fecal occult blood test (FOBT)
4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.2 Guaiac FOB stool test
4.2.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.3 Immuno-FOB agglutination test
4.2.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.4 Lateral flow immuno-FOB test
4.2.4.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.5 Immuno-FOB ELISA test
4.2.5.1 Market size, by region, 2016 – 2027 (USD Million)
4.3 Biomarker test
4.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.2 Tumor M2-PK stool test
4.3.2.1.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.3 Transferrin assays
4.3.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.4 CRC DNA screening test
4.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.2 Methylated gene test
4.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3 Panel DNA test
4.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 In-Vitro Colorectal Cancer Screening Tests Market, By End-use
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2016 – 2027 (USD Million)
5.3 Clinics
5.3.1 Market size, by region, 2016 – 2027 (USD Million)
5.4 Diagnostic laboratories
5.4.1 Market size, by region, 2016 – 2027 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 In-Vitro Colorectal Cancer Screening Tests Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2016 - 2027 (USD Million)
6.2.2 Market size, by test type, 2016 - 2027 (USD Million)
6.2.2.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.2.2.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.2.2.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.2.3 Market size, by end-use, 2016 – 2027 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by test type, 2016 - 2027 (USD Million)
6.2.4.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.2.4.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.2.4.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.2.4.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by test type, 2016 - 2027 (USD Million)
6.2.5.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.2.5.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.2.5.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.2.5.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.3 Europe
6.3.1 Market size, by country, 2016 - 2027 (USD Million)
6.3.2 Market size, by test type, 2016 - 2027 (USD Million)
6.3.2.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.2.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.2.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.3 Market size, by end-use, 2016 – 2027 (USD Million)
6.3.4 Germany
6.3.4.1 Market size, by test type, 2016 - 2027 (USD Million)
6.3.4.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.4.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.4.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.4.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.3.5 UK
6.3.5.1 Market size, by test type, 2016 - 2027 (USD Million)
6.3.5.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.5.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.5.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.5.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.3.6 France
6.3.6.1 Market size, by test type, 2016 - 2027 (USD Million)
6.3.6.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.6.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.6.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.6.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.3.7 Spain
6.3.7.1 Market size, by test type, 2016 - 2027 (USD Million)
6.3.7.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.7.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.7.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.7.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.3.8 Italy
6.3.8.1 Market size, by test type, 2016 - 2027 (USD Million)
6.3.8.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.3.8.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.3.8.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.3.8.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country, 2016 - 2027 (USD Million)
6.4.2 Market size, by test type, 2016 - 2027 (USD Million)
6.4.2.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.2.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.2.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.3 Market size, by end-use, 2016 – 2027 (USD Million)
6.4.4 China
6.4.4.1 Market size, by test type, 2016 - 2027 (USD Million)
6.4.4.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.4.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.4.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.4.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.4.5 Japan
6.4.5.1 Market size, by test type, 2016 - 2027 (USD Million)
6.4.5.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.5.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.5.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.5.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.4.6 India
6.4.6.1 Market size, by test type, 2016 - 2027 (USD Million)
6.4.6.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.6.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.6.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.6.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.4.7 Australia
6.4.7.1 Market size, by test type, 2016 - 2027 (USD Million)
6.4.7.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.7.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.7.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.7.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.4.8 South Korea
6.4.8.1 Market size, by test type, 2016 - 2027 (USD Million)
6.4.8.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.4.8.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.4.8.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.4.8.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.5 Latin America
6.5.1 Market size, by country, 2016 - 2027 (USD Million)
6.5.2 Market size, by test type, 2016 - 2027 (USD Million)
6.5.2.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.5.2.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.5.2.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.5.3 Market size, by end-use, 2016 – 2027 (USD Million)
6.5.4 Brazil
6.5.4.1 Market size, by test type, 2016 - 2027 (USD Million)
6.5.4.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.5.4.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.5.4.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.5.4.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.5.5 Mexico
6.5.5.1 Market size, by test type, 2016 - 2027 (USD Million)
6.5.5.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.5.5.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.5.5.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.5.5.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.5.6 Argentina
6.5.6.1 Market size, by test type, 2016 - 2027 (USD Million)
6.5.6.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.5.6.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.5.6.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.5.6.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.6 Middle East and Africa
6.6.1 Market size, by country, 2016 - 2027 (USD Million)
6.6.2 Market size, by test type, 2016 - 2027 (USD Million)
6.6.2.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.6.2.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.6.2.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.6.3 Market size, by end-use, 2016 – 2027 (USD Million)
6.6.4 South Africa
6.6.4.1 Market size, by test type, 2016 - 2027 (USD Million)
6.6.4.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.6.4.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.6.4.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.6.4.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by test type, 2016 - 2027 (USD Million)
6.6.5.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.6.5.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.6.5.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.6.5.2 Market size, by end-use, 2016 – 2027 (USD Million)
6.6.6 UAE
6.6.6.1 Market size, by test type, 2016 - 2027 (USD Million)
6.6.6.1.1 Market size, by fecal occult blood test (FOBT), 2016 - 2027 (USD Million)
6.6.6.1.2 Market size, by biomarker test, 2016 - 2027 (USD Million)
6.6.6.1.3 Market size, by CRC DNA screening test, 2016 - 2027 (USD Million)
6.6.6.2 Market size, by end-use, 2016 – 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Competitive dashboard, 2020
7.2 Abbott Molecular
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Epigenomics AG
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Sysmex Corporation
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Eiken Chemical
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Quest Diagnostics
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 OncoCyte Corporation-Bio time
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 BioMarCare Technologies
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Novigenix
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Randox Laboratories
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 Exact Sciences Corporation
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis
7.12 Immunostics
7.12.1 Business overview
7.12.2 Financial data
7.12.3 Product landscape
7.12.4 Strategic outlook
7.12.5 SWOT analysis
7.13 R-Biopharm Incorporation
7.13.1 Business overview
7.13.2 Financial data
7.13.3 Product landscape
7.13.4 Strategic outlook
7.13.5 SWOT analysis

Data Tables
TABLE 1. In-vitro colorectal cancer screening tests industry 360 degree synopsis, 2016-2027
TABLE 2. Global in-vitro colorectal cancer screening tests market, 2016 – 2020 (USD Million)
TABLE 3. Global in-vitro colorectal cancer screening tests market, 2021 – 2027 (USD Million)
TABLE 4. Global in-vitro colorectal cancer screening tests market, by test type, 2016 - 2020 (USD Million)
TABLE 5. Global in-vitro colorectal cancer screening tests market, by test type, 2021 – 2027 (USD Million)
TABLE 6. Global in-vitro colorectal cancer screening tests market, by end-use, 2016 - 2020 (USD Million)
TABLE 7. Global in-vitro colorectal cancer screening tests market, by end-use, 2021 – 2027 (USD Million)
TABLE 8. Global in-vitro colorectal cancer screening tests market, by region, 2016 – 2020 (USD Million)
TABLE 9. Global in-vitro colorectal cancer screening tests market, by region, 2021 – 2027 (USD Million)
TABLE 10. Industry impact forces
TABLE 11. Fecal occult blood test (FOBT) market size, by region, 2016 – 2020 (USD Million)
TABLE 12. Fecal occult blood test (FOBT)market size, by region, 2021 – 2027 (USD Million)
TABLE 13. Guaiac FOB stool test market size, by region, 2016 – 2020 (USD Million)
TABLE 14. Guaiac FOB stool test market size, by region, 2021 – 2027 (USD Million)
TABLE 15. Immuno-FOB agglutination test market size, by region, 2016 – 2020 (USD Million)
TABLE 16. Immuno-FOB agglutination test market size, by region, 2021 – 2027 (USD Million)
TABLE 17. Lateral flow immuno-FOB test market size, by region, 2016 – 2020 (USD Million)
TABLE 18. Lateral flow immuno-FOB test market size, by region, 2021 – 2027 (USD Million)
TABLE 19. Immuno-FOB ELISA test market size, by region, 2016 – 2020 (USD Million)
TABLE 20. Immuno-FOB ELISA test market size, by region, 2021 – 2027 (USD Million)
TABLE 21. Biomarker test market size, by region, 2016 – 2020 (USD Million)
TABLE 22. Biomarker test market size, by region, 2021 – 2027 (USD Million)
TABLE 23. Tumor M2-PK stool test market size, by region, 2016 – 2020 (USD Million)
TABLE 24. Tumor M2-PK stool test market size, by region, 2021 – 2027 (USD Million)
TABLE 25. Transferrin assays market size, by region, 2016 – 2020 (USD Million)
TABLE 26. Transferrin assays market size, by region, 2021 – 2027 (USD Million)
TABLE 27. CRC DNA screening test market size, by region, 2016 – 2020 (USD Million)
TABLE 28. CRC DNA screening test market size, by region, 2021 – 2027 (USD Million)
TABLE 29. Methylated gene test market size, by region, 2016 – 2020 (USD Million)
TABLE 30. Methylated gene test market size, by region, 2021 – 2027 (USD Million)
TABLE 31. Panel DNA market size, by region, 2016 – 2020 (USD Million)
TABLE 32. Panel DNA market size, by region, 2021 – 2027 (USD Million)
TABLE 33. Hospitals market size, by region, 2016 – 2020 (USD Million)
TABLE 34. Hospitals market size, by region, 2021 – 2027 (USD Million)
TABLE 35. Clinics market size, by region, 2016 – 2020 (USD Million)
TABLE 36. Clinics market size, by region, 2021 – 2027 (USD Million)
TABLE 37. Diagnostic laboratories market size, by region, 2016 – 2020 (USD Million)
TABLE 38. Diagnostic laboratories market size, by region, 2021 – 2027 (USD Million)
TABLE 39. Others market size, by region, 2016 – 2020 (USD Million)
TABLE 40. Others market size, by region, 2021 – 2027 (USD Million)
TABLE 41. North America in-vitro colorectal cancer screening tests market size, by country, 2016 - 2020 (USD Million)
TABLE 42. North America in-vitro colorectal cancer screening tests market size, by country, 2021 – 2027 (USD Million)
TABLE 43. North America in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 44. North America in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 45. North America in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 46. North America in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 - 2027 (USD Million)
TABLE 47. North America in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 – 2020 (USD Million)
TABLE 48. North America in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 49. North America in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 50. North America in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 - 2027 (USD Million)
TABLE 51. North America in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 52. North America in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 53. U.S. in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 54. U.S. in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 55. U.S. in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 56. U.S. in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 57. U.S. in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 58. U.S. in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 59. U.S. in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 60. U.S. in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 61. U.S. in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 62. U.S. in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 63. Canada in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 64. Canada in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 65. Canada in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 66. Canada in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 67. Canada in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 68. Canada in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 69. Canada in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 70. Canada in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 71. Canada in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 72. Canada in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 73. Europe in-vitro colorectal cancer screening tests market size, by country, 2016 - 2020 (USD Million)
TABLE 74. Europe in-vitro colorectal cancer screening tests market size, by country, 2021 – 2027 (USD Million)
TABLE 75. Europe in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 76. Europe in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 77. Europe in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 78. Europe in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 79. Europe in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 80. Europe in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 81. Europe in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 82. Europe in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 83. Europe in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 84. Europe in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 85. Germany in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 86. Germany in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 87. Germany in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 88. Germany in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 89. Germany in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 90. Germany in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 91. Germany in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 92. Germany in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 93. Germany in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 94. Germany in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 95. UK in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 96. UK in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 97. UK in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 98. UK in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 99. UK in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 100. UK in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 101. UK in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 102. UK in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 103. UK in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 104. UK in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 105. France in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 106. France in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 107. France in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 108. France in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 109. France in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 110. France in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 111. France in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 112. France in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 113. France in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 114. France in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 115. Spain in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 116. Spain in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 117. Spain in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 118. Spain in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 119. Spain in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 120. Spain in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 121. Spain in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TA

List of Tables

TABLE 131. Italy in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 132. Italy in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 133. Italy in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 134. Italy in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 135. Asia Pacific in-vitro colorectal cancer screening tests market size, by country, 2016 - 2020 (USD Million)
TABLE 136. Asia Pacific in-vitro colorectal cancer screening tests market size, by country, 2021 – 2027 (USD Million)
TABLE 137. Asia Pacific in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 138. Asia Pacific in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 139. Asia Pacific in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 140. Asia Pacific in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 141. Asia Pacific in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 142. Asia Pacific in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 143. Asia Pacific in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 144. Asia Pacific in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 145. Asia Pacific in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 146. Asia Pacific in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 147. China in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 148. China in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 149. China in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 150. China in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 151. China in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 152. China in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 153. China in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 154. China in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 155. China in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 156. China in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 157. Japan in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 158. Japan in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 159. Japan in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 160. Japan in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 161. Japan in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 162. Japan in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 163. Japan in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 164. Japan in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 165. Japan in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 166. Japan in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 167. India in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 168. India in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 169. India in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 170. India in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 171. India in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 172. India in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 173. India in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 174. India in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 175. India in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 176. India in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 177. Australia in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 178. Australia in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 179. Australia in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 180. Australia in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 181. Australia in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 182. Australia in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 183. Australia in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 184. Australia in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 185. Australia in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 186. Australia in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 187. South Korea in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 188. South Korea in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 189. South Korea in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 190. South Korea in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 191. South Korea in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 192. South Korea in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 193. South Korea in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 194. South Korea in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 195. South Korea in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 196. South Korea in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 197. Latin America in-vitro colorectal cancer screening tests market size, by country, 2016 - 2020 (USD Million)
TABLE 198. Latin America in-vitro colorectal cancer screening tests market size, by country, 2021 – 2027 (USD Million)
TABLE 199. Latin America in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 200. Latin America in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 201. Latin America in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 202. Latin America in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 203. Latin America in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 204. Latin America in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 205. Latin America in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 206. Latin America in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 207. Latin America in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 208. Latin America in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 209. Brazil in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 210. Brazil in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 211. Brazil in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 212. Brazil in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 213. Brazil in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 214. Brazil in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 215. Brazil in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 216. Brazil in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 217. Brazil in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 218. Brazil in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 219. Mexico in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 220. Mexico in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 221. Mexico in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 222. Mexico in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 223. Mexico in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 224. Mexico in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 225. Mexico in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 226. Mexico in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 227. Mexico in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 228. Mexico in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 229. Argentina in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 230. Argentina in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 231. Argentina in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 232. Argentina in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 233. Argentina in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 234. Argentina in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 235. Argentina in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 236. Argentina in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 237. Argentina in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 238. Argentina in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 239. MEA in-vitro colorectal cancer screening tests market size, by country, 2016 - 2020 (USD Million)
TABLE 240. MEA in-vitro colorectal cancer screening tests market size, by country, 2021 – 2027 (USD Million)
TABLE 241. MEA in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 242. MEA in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 243. MEA in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 244. MEA in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 245. MEA in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 246. MEA in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 247. MEA in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 248. MEA in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 249. MEA in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 250. MEA in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 251. South Africa in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 252. South Africa in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 253. South Africa in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 254. South Africa in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 255. South Africa in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 256. South Africa in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 257. South Africa in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 258. South Africa in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 259. South Africa in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 260. South Africa in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 261. Saudi Arabia in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 262. Saudi Arabia in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 263. Saudi Arabia in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 264. Saudi Arabia in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 265. Saudi Arabia in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 266. Saudi Arabia in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 267. Saudi Arabia in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 268. Saudi Arabia in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 269. Saudi Arabia in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 270. Saudi Arabia in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)
TABLE 271. UAE in-vitro colorectal cancer screening tests market size, by test type, 2016 - 2020 (USD Million)
TABLE 272. UAE in-vitro colorectal cancer screening tests market size, by test type, 2021 – 2027 (USD Million)
TABLE 273. UAE in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2016 - 2020 (USD Million)
TABLE 274. UAE in-vitro colorectal cancer screening tests market size, by fecal occult blood test (FOBT), 2021 – 2027 (USD Million)
TABLE 275. UAE in-vitro colorectal cancer screening tests market size, by biomarker test, 2016 - 2020 (USD Million)
TABLE 276. UAE in-vitro colorectal cancer screening tests market size, by biomarker test, 2021 – 2027 (USD Million)
TABLE 277. UAE in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2016 - 2020 (USD Million)
TABLE 278. UAE in-vitro colorectal cancer screening tests market size, by CRC DNA screening test, 2021 – 2027 (USD Million)
TABLE 279. UAE in-vitro colorectal cancer screening tests market size, by end-use, 2016 - 2020 (USD Million)
TABLE 280. UAE in-vitro colorectal cancer screening tests market size, by end-use, 2021 – 2027 (USD Million)

Charts & Figures
FIG. 1 Market estimation and forecast methodology
FIG. 2 Top-down approach (supply side analysis)
FIG. 3 Bottom-up approach (demand side analysis)
FIG. 4 Industry segmentation
FIG. 5 Global in-vitro colorectal cancer screening tests market size, 2016 – 2027 (USD Million)
FIG. 6 Growth potential analysis, by test type
FIG. 7 Growth potential analysis, by end-use
FIG. 8 Porter’s analysis
FIG. 9 Competitive matrix analysis
FIG. 10 PESTEL analysis
FIG. 11 Key segment trends, by test type
FIG. 12 Key segment trends, by end-use
FIG. 13 Key regional trends
FIG. 14 Competitive dashboard, 2020